BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9294116)

  • 1. Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus.
    Hughes SD; Lou XJ; Ighani S; Verstuyft J; Grainger DJ; Lawn RM; Rubin EM
    J Clin Invest; 1997 Sep; 100(6):1493-500. PubMed ID: 9294116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular accumulation of Lp(a): in vivo analysis of the role of lysine-binding sites using recombinant adenovirus.
    Hughes SD; Rubin EM
    Clin Genet; 1997 Nov; 52(5):361-6. PubMed ID: 9520127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative immunoassay for the lysine-binding function of lipoprotein(a). Application to recombinant apo(a) and lipoprotein(a) in plasma.
    Hoover-Plow JL; Boonmark N; Skocir P; Lawn R; Plow EF
    Arterioscler Thromb Vasc Biol; 1996 May; 16(5):656-64. PubMed ID: 8963723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions.
    Edelstein C; Mandala M; Pfaffinger D; Scanu AM
    Biochemistry; 1995 Dec; 34(50):16483-92. PubMed ID: 8845377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.
    Klezovitch O; Edelstein C; Scanu AM
    J Clin Invest; 1996 Jul; 98(1):185-91. PubMed ID: 8690792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10.
    Belczewski AR; Ho J; Taylor FB; Boffa MB; Jia Z; Koschinsky ML
    Biochemistry; 2005 Jan; 44(2):555-64. PubMed ID: 15641780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis).
    Handa JT; Tagami M; Ebrahimi K; Leibundgut G; Janiak A; Witztum JL; Tsimikas S
    Trans Am Ophthalmol Soc; 2015; 113():T5. PubMed ID: 26538774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
    Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
    Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
    Chenivesse X; Huby T; Wickins J; Chapman J; Thillet J
    Biochemistry; 1998 May; 37(20):7213-23. PubMed ID: 9585533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
    Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of apolipoprotein(a) isoform size heterogeneity on the lysine binding function of lipoprotein(a) in early onset coronary artery disease.
    Simó JM; Joven J; Vilella E; Ribas M; Pujana MA; Sundaram IM; Hammel JP; Hoover-Plow JL
    Thromb Haemost; 2001 Mar; 85(3):412-7. PubMed ID: 11307806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site.
    Hermann A; Laws WR; Harpel PC
    Protein Sci; 1997 Nov; 6(11):2324-35. PubMed ID: 9385634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
    Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
    Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) assembly. Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation.
    Gabel BR; May LF; Marcovina SM; Koschinsky ML
    Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1559-67. PubMed ID: 8977462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.
    Mochalkin I; Cheng B; Klezovitch O; Scanu AM; Tulinsky A
    Biochemistry; 1999 Feb; 38(7):1990-8. PubMed ID: 10026282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of fibrinolysis by lipoprotein(a).
    Anglés-Cano E; de la Peña Díaz A; Loyau S
    Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single point mutation (Trp72-->Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a).
    Scanu AM; Pfaffinger D; Lee JC; Hinman J
    Biochim Biophys Acta; 1994 Oct; 1227(1-2):41-5. PubMed ID: 7918682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).
    Ernst A; Helmhold M; Brunner C; Pethö-Schramm A; Armstrong VW; Müller HJ
    J Biol Chem; 1995 Mar; 270(11):6227-34. PubMed ID: 7890760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a).
    Leibundgut G; Scipione C; Yin H; Schneider M; Boffa MB; Green S; Yang X; Dennis E; Witztum JL; Koschinsky ML; Tsimikas S
    J Lipid Res; 2013 Oct; 54(10):2815-30. PubMed ID: 23828779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine-binding heterogeneity of Lp(a): consequences for fibrin binding and inhibition of plasminogen activation.
    Bas Leerink C; Duif PF; Gimpel JA; Kortlandt W; Bouma BN; van Rijn HJ
    Thromb Haemost; 1992 Aug; 68(2):185-8. PubMed ID: 1412165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.